Get in touch
Please contact us to discuss how working with Myriad Associates can maximise and secure R&D funding opportunities for your business.
Competition opens: Monday 3 September 2018
Competition closes: Wednesday 31 October 2018 12:00 pm
Award: Feasibility studies’ total eligible project costs can be between £50,000 and £75,000. All projects must start by 1 April 2019 and can last up to 12 months.
Summary:
The Digital Health Technology Catalyst (DHTC) is a £35 million fund, being run over 4 years. It is part of the Industrial Strategy Challenge Fund.
Innovate UK, as part of UK Research and Innovation, is to invest up to £1 million in feasibility studies that can potentially develop new digital technology solutions to healthcare challenges. They are running another competition in parallel focusing on industrial research and development.
You must show how your project will improve the competitiveness and productivity of at least one UK SME involved in the project. SMEs can work alone or in collaboration.
Aligned with the Industrial Strategy and the Accelerated Access Review, the aims of this competition are to:
You can develop solutions for either clinical or non-clinical use.
Projects must be innovative and clearly demonstrate how they will have the potential to improve the health and care system.
Innovate UK has set out the following areas of importance as a guide to what they are looking for. This should not limit the scope of any potential projects.
1. Improving health, and closing the health and wellbeing gap with:
2. Transforming care, and closing the care and quality gap with:
3. Controlling costs, enabling change and closing the finance and efficiency gap. This will be through the use of technology to maintain or improve levels of care with reduced spending.
Innovate UK will select and fund a portfolio of projects showing the potential for significant innovation. Proposals must improve business growth, improve productivity or create opportunities for at least one UK SME involved in the project.
The grant enables you to explore and evaluate the commercial potential of an early-stage digital health concept. This can be through (but not limited to):
State clearly what unmet healthcare need you are addressing, which technologies you are using and, if applicable, which stage of the patient experience it relates to.
Thinking of applying? Let us help improve your chances of winning.
Click here for a free eligibility call
This post was written by Barrie Dowsett who is Chief Executive Officer at Myriad Associates . Click here to read more about Barrie and the Myriad team.
Please contact us to discuss how working with Myriad Associates can maximise and secure R&D funding opportunities for your business.